Independent fund research. Built on SEC filings.

How we research funds

Mutual fund · Health Care Sector · Alger

Alger Health Sciences Fund Alger Health Sciences Fund Class C (AHSCX)

Ticker AHSCX · Since 2002-05-01 · · Holdings as of Jul 31, 2026

Expense ratio
1.96%$196/yr per $10k
5-yr return
−2.7%annualized
1-yr return
+8.2%as of Dec 2025
Net assets
$75.4Mall share classes
Holdings
55

Bottom line

Is AHSCX a good fund? The bottom line

AHSCX is a share class of Alger Health Sciences Fund, a managed health care sector mutual fund from Alger.

Its expense ratio is 1.96% — about $196 a year on every $10,000 invested, more expensive than 93% of health care sector funds we track.

It returned +8.2% over one year, −2.7% a year over five years, +6.7% a year over ten (as of Dec 31, 2025, per its prospectus).

With $75.4 million in net assets and 55 holdings, its largest position is Dreyfus Treasury Obligations Cash Management (6.5%) and the top 10 make up 42.3% of the portfolio.

What stands out

  • No front-end sales load

What to watch

  • Expensive for its category (1.96%)
  • 5-year return in the bottom quarter of its category
  • 12b-1 marketing fee of 1% a year
  • High turnover (289% a year) can mean more taxable distributions

Updated Nov 19, 2026

What AHSCX invests in

Alger Health Sciences Fund seeks long-term capital appreciation.

The Manager believes companies undergoing Positive Dynamic Change offer the best opportunities. Positive Dynamic Change refers to companies realizing High Unit Volume Growth or companies undergoing Positive Lifecycle Change. High Unit Volume Growth companies are traditional growth companies experiencing, for example, rapidly growing demand or market dominance. Positive Lifecycle Change companies are, for example, companies benefitting from new regulations, a new product innovation or new management. Under normal circumstances, the Fund invests at least 80% of its net assets, plus any borrowings for investment purposes, in equity securities of companies of any market capitalization that are engaged in the health sciences sector. Equity securities include common or preferred stocks that are listed on U.S. or foreign exchanges. A company will be considered to be engaged in the health…

From the fund's prospectus (filed Mar 5, 2026).

AHSCX performance

Average annual total returns
1 yr5 yr10 yr
AHSCX+8.2%−2.7%+6.7%
Health Care Sector median+14.5%+4.2%+7.9%

Source: Fund prospectus, as of Dec 31, 2025

Full AHSCX performance history →

What AHSCX costs

On a $10,000 investment, AHSCX's 1.96% expense ratio costs about $196 a year. The prospectus estimates $2,285 in total costs over 10 years (assuming 5% annual returns). The median health care sector fund charges 0.96%.

See the full AHSCX fee table →

AHSCX top 10 holdings

#Holding% of fund
1Dreyfus Treasury Obligations Cash Management6.51%
2Impulse Dynamics Ireland4.27%
3Merck & Company Inc MRK4.18%
4Welltower Inc WELL4.12%
5Johnson & Johnson JNJ4.06%
6Thermo Fisher Scientific Inc TMO4.00%
7Bruker Corp BRKR3.98%
8Illumina Inc ILMN3.95%
9Cvs Health Corp CVS3.67%
10Unitedhealth Group Inc UNH3.61%

Source: SEC Form N-PORT, period ended Jul 31, 2026

The top 10 make up 42.3% of the fund. See all top 25 holdings and asset mix →

Alternatives to AHSCX

More funds like AHSCX →

AHSCX FAQ

What is the expense ratio of AHSCX?
AHSCX's expense ratio is 1.96%, which works out to about $196 a year for every $10,000 invested. The prospectus estimates total costs of $2,285 over 10 years on a $10,000 investment (assuming 5% annual returns).
Is AHSCX a good investment?
It depends on your goals, but the data points to: no front-end sales load; expensive for its category (1.96%); 5-year return in the bottom quarter of its category; 12b-1 marketing fee of 1% a year; high turnover (289% a year) can mean more taxable distributions. This is general information, not personalized advice.
What does AHSCX hold?
AHSCX's largest holdings are Dreyfus Treasury Obligations Cash Management (6.5%), Impulse Dynamics Ireland (4.3%), Merck & Company Inc (4.2%), Welltower Inc (4.1%), Johnson & Johnson (4.1%). It holds 55 positions in total as of Jul 31, 2026 (SEC Form N-PORT).
What is AHSCX's 5-year return?
AHSCX returned −2.7% a year over the five years ending Dec 31, 2025, and +6.7% a year over ten years. Past performance does not guarantee future results.
Does AHSCX have a sales load?
No. AHSCX has no front-end sales charge. It may charge a deferred sales charge of up to 1% if sold early.
Who manages AHSCX?
AHSCX is offered by Alger through Alger Funds.